Zimmer Partners LP decreased its position in PACS Group, Inc. (NYSE:PACS - Free Report) by 16.4% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,947,229 shares of the company's stock after selling 382,300 shares during the period. Zimmer Partners LP owned 1.28% of PACS Group worth $25,528,000 as of its most recent filing with the SEC.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. State of Wyoming purchased a new stake in shares of PACS Group during the 4th quarter worth approximately $47,000. KLP Kapitalforvaltning AS purchased a new stake in shares of PACS Group during the 4th quarter worth approximately $126,000. Savant Capital LLC purchased a new stake in shares of PACS Group during the 4th quarter worth approximately $142,000. ProShare Advisors LLC increased its stake in shares of PACS Group by 45.4% during the 4th quarter. ProShare Advisors LLC now owns 10,855 shares of the company's stock worth $142,000 after purchasing an additional 3,391 shares during the last quarter. Finally, XTX Topco Ltd purchased a new stake in shares of PACS Group during the 4th quarter worth approximately $161,000.
PACS Group Trading Down 1.5%
Shares of PACS stock opened at $10.65 on Tuesday. The company has a 50 day moving average of $10.29 and a 200-day moving average of $13.30. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.71 and a current ratio of 1.71. PACS Group, Inc. has a 12-month low of $8.28 and a 12-month high of $43.92.
PACS Group Company Profile
(
Free Report)
PACS Group, Inc, through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider PACS Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and PACS Group wasn't on the list.
While PACS Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.